FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

30915811000001100: Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Nov 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95498501000001112 Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
95498601000001111 Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely valproate sodium 200 milligram/1 each gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Valproate sodium false Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Valproate sodium true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has AMP True Sodium valproate 200mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start